🔎 Trials Near Me

Dachaigh › Ailseachadh nan Sgamhan › Maryland

Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Maryland

Tha 56 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann an Maryland.

Bailtean ann an Maryland

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Luminis Health Anne Arundel Medical Center, Annapolis
  • Greater Baltimore Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • agus 7 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04267848

Evaluation for NCI Surgery Branch Clinical Research Protocols

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00001823

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 2 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00242723

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01950572

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06885697

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

  • MedStar Franklin Square Medical Center ( Site 0033), Baltimore
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06780098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • agus 10 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01441089

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, Baltimore
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster
A’ fastadhÌre 3
Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
  • UPMC Western Maryland, Cumberland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Johns Hopkins University of Medicine, Baltimore
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06881784

DK222 Study at Hopkins

  • Johns Hopkins Hospital, Baltimore
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07140315

Collection of Blood From Patients With Cancer

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00034216

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Maryland Oncology Hematology, P.A., Annapolis
  • Maryland Oncology Hematology, P.A., Bethesda
  • Maryland Oncology Hematology, P.A., Brandywine
  • agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07222566

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07154290

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Baltimore
A’ fastadhÌre 2
Aoisean 18 gu 95 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06712316

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • Johns Hopkins, Baltimore
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07349537

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06287775

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • Saint Agnes Hospital - Baltimore - Hunt - PPDS, Baltimore
  • Walter Reed National Military Medical Center, Bethesda
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Johns Hopkins Bayview Medical Center, Baltimore
  • USO - Maryland Oncology Hematology, Columbia
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06119581

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Walter Reed National Military Medical Center, Bethesda
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06995898

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06712355

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 2
Aoisean 18 gu 72 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT02133196

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

  • MedStar Franklin Square Medical Center ( Site 0033), Baltimore
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06731907

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Greater Baltimore Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • TidalHealth Richard A Henson Cancer Institute, Ocean Pines
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • National Institutes of Health, Bethesda
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

  • Johns Hopkins University, Baltimore
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT05995821

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

  • University of Maryland Baltimore Washington Medical Center, Glen Burnie
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07008664

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Iuch 2026 · NCT05652686

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

  • Maryland Oncology Hematology, Calverton
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07315113

EXoPERT EMERALD Clinical Study

  • John Hopkins University, Baltimore
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 45 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT07186296

Integrated Cancer Repository for Cancer Research

  • Northwest Hospital, Randallstown
  • William E. Kahlert Regional Cancer Center, Westminster
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

GCC 2546- Motion Management

  • University of Maryland Greenebaum Cancer Center, Baltimore
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT07398209

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT00451022

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Kaiser Permanente-Woodlawn Medical Center, Baltimore
  • UPMC Western Maryland, Cumberland
  • Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Johns Hopkins University, Baltimore
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT06040541

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.